Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics-Reference-Cited by-同舟云学术

Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics

Published:2010-10-15 Issue:44 Volume:107 Page:18874-18879
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Wei X.,Dombkowski D.,Meirelles K.,Pieretti-Vanmarcke R.,Szotek P. P.,Chang H. L.,Preffer F. I.,Mueller P. R.,Teixeira J.,MacLaughlin D. T.,Donahoe P. K.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference62 articles.

1. Prospective identification of tumorigenic breast cancer cells

2. Stem and Progenitor-Like Cells Contribute to the Aggressive Behavior of Human Epithelial Ovarian Cancer

3. Identification of Pancreatic Cancer Stem Cells

4. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

5. Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways;International Journal of Molecular Sciences;2024-04-07

2. CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulation;Cell Death Discovery;2024-02-15

3. Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer;Nature Communications;2024-02-13

4. Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment;Asian Journal of Pharmaceutical Sciences;2023-09

5. Stem cell properties of cancer cells in ascitic fluid of patients with ovarian cancer: a key to control over cancer progression;Bulletin of Siberian Medicine;2023-07-09